Intratumoral drug distribution of adavosertib in patients with glioblastoma: Interim results of phase I study.

2568Background: Wee1 is a key regulator of the G2/M checkpoint and is frequently overexpressed in glioblastoma (GB). Adavosertib is a first-in-class oral, small molecule inhibitor of Wee1 that acts...